tiprankstipranks
Advertisement
Advertisement
Chemours price target lowered to $18 from $21 at Morgan Stanley
PremiumThe FlyChemours price target lowered to $18 from $21 at Morgan Stanley
28d ago
Chemours downgraded to Neutral from Buy at UBS
Premium
The Fly
Chemours downgraded to Neutral from Buy at UBS
29d ago
Chemours price target lowered to $24 from $30 at Truist
Premium
The Fly
Chemours price target lowered to $24 from $30 at Truist
1M ago
Closing Bell Movers: SpaceX slips after first quarterly report as public company
PremiumThe FlyClosing Bell Movers: SpaceX slips after first quarterly report as public company
1M ago
Chemours sees Q3 revenue down 5% to flat, consensus $1.6B
Premium
The Fly
Chemours sees Q3 revenue down 5% to flat, consensus $1.6B
1M ago
Chemours sees FY26 revenue growth 1%-5% vs. FY25, consensus $6.05B
Premium
The Fly
Chemours sees FY26 revenue growth 1%-5% vs. FY25, consensus $6.05B
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100